We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in both the EU and US.
Batavia Biosciences aims to significantly contribute to ease human suffering from infectious disease and cancer.
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 4, 2019 | Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic | Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic 04-09-2019 Batavia Biosciences announced that the company has signed a licence agreement to utilise Horizon Discovery’s GS knockout CH... |
| Dec 29, 2016 | Univercells Receives $12M Grant by Bill & Melinda Gates Foundation | Univercells, a Gosselies – Belgium-based developer of a vaccine manufacturing platform, received a $12m grant by the Bill & Melinda Gates Foundation. The company will use the funds for the development of a vaccine manufacturing platform... |
Reviews 0
FAQ about Batavia Biosciences
When was Batavia Biosciences founded?
Batavia Biosciences was founded in 2010.
What has the press written about Batavia Biosciences?
Parsers VC has collected 3 articles mentioning Batavia Biosciences, among them “Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic” (Sep 4, 2019) and “Univercells Receives $12M Grant by Bill & Melinda Gates Foundation” (Dec 29, 2016).
Is Batavia Biosciences still active?
Yes, Batavia Biosciences is active; its latest activity on Parsers VC dates from Sep 4, 2019.